PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
All content for PeerVoice Heart & Lung Video is the property of PeerVoice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Geoffrey Liu, MD, MSc, FRCPC, FISPE - Optimizing the Potential for Patients With ALK-Positive mNSCLC Throughout Their Treatment Journey
PeerVoice Heart & Lung Video
14 minutes 30 seconds
1 year ago
Geoffrey Liu, MD, MSc, FRCPC, FISPE - Optimizing the Potential for Patients With ALK-Positive mNSCLC Throughout Their Treatment Journey
Visit https://www.peervoice.com/GFE860 to view the entire programme with slides. After completing “Geoffrey Liu, MD, MSc, FRCPC, FISPE - Optimizing the Potential for Patients With ALK-Positive mNSCLC Throughout Their Treatment Journey”, participants will be able to: Discuss the importance of first-line treatment and the factors to consider when selecting a treatment strategy for patients with ALK-positive metastatic non–small-cell lung cancer (mNSCLC); Describe the evolving clinical evidence and guideline recommendations for the treatment of ALK-positive mNSCLC; Review the toxicities of the new generation tyrosine kinase inhibitors (TKIs) used as first-line in the treatment of ALK-positive mNSCLC; and Apply key learnings and strategies to enhance the toxicity management of new generation TKIs for optimal patient outcomes.
PeerVoice Heart & Lung Video
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
